| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| GRAIL | 16 | - | -51,74 % | ||
| BIONTECH | 10 | 13 | -0,11 % | ||
| MODERNA | 9 | 16 | -0,56 % | ||
| GUARDANT HEALTH | 9 | 2 | -5,60 % | ||
| ARDELYX | 8 | 8 | -14,86 % | ||
| CANDEL THERAPEUTICS | 8 | 1 | -14,96 % | ||
| PTC THERAPEUTICS | 6 | 4 | -1,68 % | ||
| SPYRE THERAPEUTICS | 5 | 3 | +1,24 % | ||
| PROTHENA | 5 | 1 | 0,00 % | ||
| TRAVERE THERAPEUTICS | 4 | 11 | -5,60 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21:06 | Madrigal Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) | 2 | Benzinga.com | ||
| 20:31 | Here's Why Grail Stock Crashed 50% Today | 4 | The Motley Fool | ||
| 20:26 | Ionis scraps early candidate for Alzheimer's in people with Down syndrome | 1 | FierceBiotech | ||
| 20:15 | Dividendenbekanntmachungen (20.02.2026) | 2.205 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ASX LIMITED AU000000ASX7 1,018 AUD 0,6103 EUR ATMUS FILTRATION TECHNOLOGIES INC US04956D1072 0,055 USD 0,0467 EUR AUDIOCODES LTD IL0010829658 0... ► Artikel lesen | |
| 19:31 | Is CRISPR Therapeutics Stock Going to $0, or Will the Hype Pay Off? | 2 | The Motley Fool | ||
| 19:30 | PTC Therapeutics outlines 19%-36% 2026 product revenue growth target as Sephience momentum accelerates globally | 2 | Seeking Alpha | ||
| 19:30 | Hims latest offering, Grail's Galleri cancer test, fails U.K. study | 16 | Seeking Alpha | ||
| 19:06 | Breaking Down Insmed: 16 Analysts Share Their Views | 3 | Benzinga.com | ||
| 19:06 | A Glimpse of Vir Biotechnology's Earnings Potential | 4 | Benzinga.com | ||
| 18:50 | Blitz-Update: Dow & Co uneinheitlich - Amazon, Salesforce, Apple stark, Chemours, Grail sacken ... | 343 | Der Aktionär | Die US-Börsen finden im frühen Handel am Freitag keine einheitliche Richtung. Der Leitindex Dow Jones Industrial verliert 0,3 Prozent auf 49.243,25 Zähler. Der marktbreite S&P 500 legt hingegen 0,1... ► Artikel lesen | |
| 18:30 | Ardelyx's post-earnings decline attributed to concerns over Ibsrela outlook | 10 | Seeking Alpha | ||
| 18:18 | Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results | 2 | Benzinga.com | ||
| 18:06 | Axsome Therapeutics' Earnings Outlook | 1 | Benzinga.com | ||
| 17:59 | GRAIL Shares Plunge 45% After NHS-Galleri Trial Misses Primary Endpoint | 11 | RTTNews | ||
| 17:58 | Kiniksa Pharmaceuticals-Aktie erreicht Rekordhoch bei 47,86 USD | 1 | Investing.com Deutsch | ||
| 17:54 | Regenxbio dealt win by appeals court in patent spat with Sarepta | 2 | Seeking Alpha | ||
| 17:46 | Madrigal sees a stock sell-off; ex-Novartis exec heads to Daiichi | 4 | BioPharma Dive | ||
| 17:18 | Stifel raises Guardant Health stock price target on guidance outlook | 2 | Investing.com | ||
| 17:15 | Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise | 1 | MarketBeat | ||
| 17:12 | Galapagos Q4 2025 Earnings Preview | 2 | Seeking Alpha |